GEN Exclusives

More »

The Lists

More »
Aug 28, 2012

Top 25 Biotech Companies

Did your company make the list?

Top 25 Biotech Companies

These firms are currently doing the best in the business, based on market capitalization at the end of Q2 2012, and Q2 2011. [© Lane Erickson - Fotolia.com]

  • Below are the top 25 biotechnology companies based on market capitalization at the end of the second quarter 2012, and Q2 2011, calculated by multiplying the number of outstanding shares by the share price. U.S. companies generally report their numbers of outstanding shares in their 10-Q quarterly earnings filings with the Securities & Exchange Commission. Companies based outside the U.S. either disclose market cap directly, or their numbers of shares “in issue” or “in free issue” in half-year and full-year results disclosures.

    For all companies, closing share prices as of the dates of their outstanding-shares figures can be found through any of several free stock information websites. Figures of non-U.S. companies were converted to U.S. dollars from various currencies. 2012 market cap for companies reporting numbers of outstanding shares as of June 30 was calculated using share prices as of June 29, since markets were closed on June 30.

  • #25. Seattle Genetics

    2012 Market Cap: $2.92 billion (8/2: 118,207,214 shares at price $24.72)

    2011 Market Cap: $1.89 billion (8/1: 114,730,639 shares at price $16.45)

    % Change: 54.5%

  • #24. Ariad Pharmaceuticals

    2012 Market Cap: $3.18 billion (7/31: 166,204,624 shares * price $19.13)

    2011 Market Cap: $1.58 billion (7/29: 132,547,176 shares * price $11.89)

    % Change: 101.3%

  • #23. Medivation

    2012 Market Cap: $3.65 billion (8/3: 36,832,178 shares * price $99.04)

    2011 Market Cap: $683.85 million (8/3: 34,907,994 shares *price $19.59)

    % Change: 433.4%

  • #22. Ranbaxy Laboratories

    2012 Market Cap: $3.71 billion (6/30: 422,112,588 shares * price Rs. 490.55)

    2011 Market Cap: $4.08 billion (6/30: 421,363,230 shares * price Rs. 540.35)

    % Change: -9.1%

  • #21. Warner Chilcott

    2012 Market Cap: $4.49 billion (7/20: 250,482,397 shares * price $17.91)

    2011 Market Cap: $5.69 billion (7/25: 254,075,621 shares * price $22.40)

    % Change: -21.1%

  • #20. Actelion

    2012 Market Cap: $4.65 billion (6/30: 116,860,000 shares * price €32.20)

    2011 Market Cap: $5.02 billion (6/30: 119,164,000 shares * price €34.09)

    % Change: -7.4%

  • #19. Onyx Pharmaceuticals1

    2012 Market Cap: $5.06 billion (7/27: 65,095,777 shares * price $77.73)

    2011 Market Cap: $2.10 billion (7/29: 63,544,578 shares * price $32.98)

    % Change: 141.0%

  • #18. Amylin Pharmaceuticals1,2

    2012 Market Cap: $5.06 billion (7/27: 164,283,038 shares * price $30.80)

    2011 Market Cap: $1.74 billion (7/27: 145,893,374 shares * price $11.96)

    % Change: 190.8%

  • #17. Dr. Reddy’s Laboratories3,4

    2012 Market Cap: $5.35 billion (3/31: 169,470,729 shares * price: Rs 1758.65)

    2011 Market Cap: $5.03 billion (3/31: 169,128,649 shares * price: Rs. 1638.55)

    % Change: 6.4%

  • #16. BioMarin Pharmaceuticals4

    2012 Market Cap: $5.35 billion (7/13: 123,555,244 shares * price $43.30)

    2011 Market Cap: $3.32 billion (7/15: 111,827,290 shares * price $29.69)

    % Change: 61.1%


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Companion Animal Care

Do you think Americans spend too much on companion animal care?